SKVI (Skinvisible) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SKVI Skinvisible Inc SKVI
14 GF Score
Price $0.18
GF Value $0.22
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Skinvisible Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SKVI
14GF Score
Skinvisible Inc SKVI
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Skinvisible (SKVI) Overvalued in 2026?

Based on GuruFocus' analysis, Skinvisible stock appears to be undervalued. The current stock price of $0.18 is trading 18.2% below its estimated GF Value™ of $0.22. GuruFocus considers Skinvisible to be Modestly Undervalued.

Key valuation signals for SKVI:

  • Short Ratio:
  • GF Value™: $0.22 vs. price of $0.18 (18.2% below fair value)
  • GF Score™: 14/100 with 6 warning signs

No single metric tells the full story. See the SKVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Skinvisible Business Description

Address 6320 South Sandhill Road, Unit 9, Las Vegas, NV, USA, 89120
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare, and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active.
14GF Score

Get the complete analysis for SKVI

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.18
Price
$0.22
GF Value